Usage: LACRISERT treats moderate to severe dry eye syndromes, including keratoconjunctivitis sicca, especially in patients unresponsive to artificial tears. Also indicated for exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Usage: Restasis increases tear production in patients with dry eye disease (keratoconjunctivitis sicca) where tear production is suppressed due to ocular inflammation. Not effective in patients currently using topical anti-inflammatory eye drops or punctal plugs.